400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Membrane Transporter/Ion Channel / Chloride Channel & Quinones / 紫草素
CAS No.: 517-89-5
Synonyms: 紫草素;C.I. 75535;Isoarnebin 4
Shikonin is an inhibitor of TMEM16A chloride channel with IC50 of 6.5 μM, it's a natural product isolated and purified from the roots of Lithosperraum erythrorhizon Sieb. et Zucc..
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT01968928 | - | - | Unknown | December 2016 | Taiwan ... more >> Department of Urology, National Taiwan University Hospital Not yet recruiting Taipei, Taiwan, 10002 Contact: Kuo-How Huang, M.D.,Ph.D. 886-2-23123456 ext 65952 khhuang123@ntu.edu.tw Principal Investigator: Kuo-How Huang, M.D.,Ph.D. Collapse << |
NCT01287468 | - | - | Unknown | December 2014 | Taiwan ... more >> Taipei Medical University - WanFang Hospital Taipei, Taiwan Collapse << |
实验方案
技术信息
CAS号 | 517-89-5 | 储存条件 |
|
|||||||||||
分子式 | C16H16O5 | 运输 | 蓝冰 | |||||||||||
分子量 | 288.30 | 别名 | 紫草素;C.I. 75535;Isoarnebin 4 | |||||||||||
溶解度 |
|
动物实验配方 |
|
Cell Lines | Concentration | Assay Type | Time | Activity Description | Data Sources |
---|
8-MG-BA cell | - | Growth inhibition assay | - | Inhibition of human 8-MG-BA cell growth in a cell viability assay, IC50=85.56 nM | SANGER |
A101D cell | - | Growth inhibition assay | - | Inhibition of human A101D cell growth in a cell viability assay, IC50=0.712 nM | SANGER |
A204 cell | - | Growth inhibition assay | - | Inhibition of human A204 cell growth in a cell viability assay, IC50=0.12654 μM | SANGER |
A253 cell | - | Growth inhibition assay | - | Inhibition of human A253 cell growth in a cell viability assay, IC50=7.49 nM | SANGER |
A427 cell | - | Growth inhibition assay | - | Inhibition of human A427 cell growth in a cell viability assay, IC50=17.99 nM | SANGER |
A431 cell | - | Growth inhibition assay | - | Inhibition of human A431 cell growth in a cell viability assay, IC50=0.10697 μM | SANGER |
A498 cell | - | Growth inhibition assay | - | Inhibition of human A498 cell growth in a cell viability assay, IC50=81.9 nM | SANGER |
ACHN cell | - | Growth inhibition assay | - | Inhibition of human ACHN cell growth in a cell viability assay, IC50=0.14638 μM | SANGER |
AM-38 cell | - | Growth inhibition assay | - | Inhibition of human AM-38 cell growth in a cell viability assay, IC50=96.31 nM | SANGER |
AN3-CA cell | - | Growth inhibition assay | - | Inhibition of human AN3-CA cell growth in a cell viability assay, IC50=79.65 nM | SANGER |
BT-474 cell | - | Growth inhibition assay | - | Inhibition of human BT-474 cell growth in a cell viability assay, IC50=0.20836 μM | SANGER |
CA46 cell | - | Growth inhibition assay | - | Inhibition of human CA46 cell growth in a cell viability assay, IC50=0.19185 μM | SANGER |
CAL-51 cell | - | Growth inhibition assay | - | Inhibition of human CAL-51 cell growth in a cell viability assay, IC50=20.85 nM | SANGER |
CAL-85-1 cell | - | Growth inhibition assay | - | Inhibition of human CAL-85-1 cell growth in a cell viability assay, IC50=0.16073 μM | SANGER |
CHL-1 cell | - | Growth inhibition assay | - | Inhibition of human CHL-1 cell growth in a cell viability assay, IC50=0.1678 μM | SANGER |
COLO-679 cell | - | Growth inhibition assay | - | Inhibition of human COLO-679 cell growth in a cell viability assay, IC50=0.18401 μM | SANGER |
COR-L105 cell | - | Growth inhibition assay | - | Inhibition of human COR-L105 cell growth in a cell viability assay, IC50=0.23034 μM | SANGER |
Daoy cell | - | Growth inhibition assay | - | Inhibition of human Daoy cell growth in a cell viability assay, IC50=0.15877 μM | SANGER |
DEL cell | - | Growth inhibition assay | - | Inhibition of human DEL cell growth in a cell viability assay, IC50=0.15381 μM | SANGER |
DU-145 cell | - | Growth inhibition assay | - | Inhibition of human DU-145 cell growth in a cell viability assay, IC50=0.19309 μM | SANGER |
DU-4475 cell | - | Growth inhibition assay | - | Inhibition of human DU-4475 cell growth in a cell viability assay, IC50=0.17984 μM | SANGER |
EFM-19 cell | - | Growth inhibition assay | - | Inhibition of human EFM-19 cell growth in a cell viability assay, IC50=0.2121 μM | SANGER |
G-401 cell | - | Growth inhibition assay | - | Inhibition of human G-401 cell growth in a cell viability assay, IC50=0.23492 μM | SANGER |
GCIY cell | - | Growth inhibition assay | - | Inhibition of human GCIY cell growth in a cell viability assay, IC50=35.98 nM | SANGER |
GR-ST cell | - | Growth inhibition assay | - | Inhibition of human GR-ST cell growth in a cell viability assay, IC50=0.10218 μM | SANGER |
HAL-01 cell | - | Growth inhibition assay | - | Inhibition of human HAL-01 cell growth in a cell viability assay, IC50=0.19573 μM | SANGER |
HCT116 cells | - | Cytotoxicity assay | 24 h | Cytotoxicity against MDR1 Pgp under-expressing human HCT116 cells after 24 hrs by MTT assay, IC50=0.23 μM | 17949858 |
HCT15 cells | - | Function assay | 24 h | Antitumor activity against human HCT15 cells after 24 hrs by MTT assay, IC50=7.3 μM | 21620530 |
HepG2 cell | - | Cytotoxicity assay | 24 h | Cytotoxicity against MDR1 Pgp overexpressing human HepG2 cells after 24 hrs by MTT assay, IC50=0.24 μM | 17949858 |
HGC-27 cell | - | Growth inhibition assay | - | Inhibition of human HGC-27 cell growth in a cell viability assay, IC50=0.22834 μM | SANGER |
HL60 cells | - | Cytotoxicity assay | - | Cytotoxicity against human HL60 cells by MTT assay, IC50=0.44 μM | 19111464 |
HLE cell | - | Growth inhibition assay | - | Inhibition of human HLE cell growth in a cell viability assay, IC50=88.31 nM | SANGER |
HMV-II cell | - | Growth inhibition assay | - | Inhibition of human HMV-II cell growth in a cell viability assay, IC50=56.4 nM | SANGER |
HOS cell | - | Growth inhibition assay | - | Inhibition of human HOS cell growth in a cell viability assay, IC50=0.18608 μM | SANGER |
HSC-2 cell | - | Growth inhibition assay | - | Inhibition of human HSC-2 cell growth in a cell viability assay, IC50=0.22318 μM | SANGER |
IGR-1 cell | - | Growth inhibition assay | - | Inhibition of human IGR-1 cell growth in a cell viability assay, IC50=0.15398 μM | SANGER |
IGROV-1 cell | - | Growth inhibition assay | - | Inhibition of human IGROV-1 cell growth in a cell viability assay, IC50=55.61 nM | SANGER |
IST-SL2 cell | - | Growth inhibition assay | - | Inhibition of human IST-SL2 cell growth in a cell viability assay, IC50=0.20014 μM | SANGER |
J82 cell | - | Growth inhibition assay | - | Inhibition of human J82 cell growth in a cell viability assay, IC50=0.14255 μM | SANGER |
KASUMI-1 cell | - | Growth inhibition assay | - | Inhibition of human KASUMI-1 cell growth in a cell viability assay, IC50=0.12371 μM | SANGER |
KS-1 cell | - | Growth inhibition assay | - | Inhibition of human KS-1 cell growth in a cell viability assay, IC50=41.5 nM | SANGER |
KU812 cell | - | Growth inhibition assay | - | Inhibition of human KU812 cell growth in a cell viability assay, IC50=8.31 nM | SANGER |
KYSE-270 cell | - | Growth inhibition assay | - | Inhibition of human KYSE-270 cell growth in a cell viability assay, IC50=0.21692 μM | SANGER |
KYSE-450 cell | - | Growth inhibition assay | - | Inhibition of human KYSE-450 cell growth in a cell viability assay, IC50=0.13815 μM | SANGER |
LB647-SCLC cell | - | Growth inhibition assay | - | Inhibition of human LB647-SCLC cell growth in a cell viability assay, IC50=0.23278 μM | SANGER |
M059J cell | - | Growth inhibition assay | - | Inhibition of human M059J cell growth in a cell viability assay, IC50=0.13419 μM | SANGER |
MCF7 cells | - | Cytotoxicity assay | 72 h | Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay, IC50=1.45 μM | 20403646 |
MDA-MB-231 cells | - | Function assay | 24 h | Antitumor activity against human MDA-MB-231 cells after 24 hrs by MTT assay, IC50=6.6 μM | 21620530 |
MEL-HO cell | - | Growth inhibition assay | - | Inhibition of human MEL-HO cell growth in a cell viability assay, IC50=0.14882 μM | SANGER |
MES-SA cell | - | Growth inhibition assay | - | Inhibition of human MES-SA cell growth in a cell viability assay, IC50=41.32 nM | SANGER |
MKN1 cell | - | Growth inhibition assay | - | Inhibition of human MKN1 cell growth in a cell viability assay, IC50=0.23576 μM | SANGER |
mouse L929 cells | - | Cytotoxicity assay | 24 h | Cytotoxicity against mouse L929 cells after 24 hrs by MTT assay, IC50=3.2 μM | 21620530 |
MRK-nu-1 cell | - | Growth inhibition assay | - | Inhibition of human MRK-nu-1 cell growth in a cell viability assay, IC50=0.10193 μM | SANGER |
MZ1-PC cell | - | Growth inhibition assay | - | Inhibition of human MZ1-PC cell growth in a cell viability assay, IC50=19.28 nM | SANGER |
MZ7-mel cell | - | Growth inhibition assay | - | Inhibition of human MZ7-mel cell growth in a cell viability assay, IC50=0.11372 μM | SANGER |
NALM-6 cell | - | Growth inhibition assay | - | Inhibition of human NALM-6 cell growth in a cell viability assay, IC50=2.8 nM | SANGER |
NB69 cell | - | Growth inhibition assay | - | Inhibition of human NB69 cell growth in a cell viability assay, IC50=0.21273 μM | SANGER |
NCI-H1963 cell | - | Growth inhibition assay | - | Inhibition of human NCI-H1963 cell growth in a cell viability assay, IC50=0.10011 μM | SANGER |
NCI-H2009 cell | - | Growth inhibition assay | - | Inhibition of human NCI-H2009 cell growth in a cell viability assay, IC50=20.54 nM | SANGER |
NCI-H2052 cell | - | Growth inhibition assay | - | Inhibition of human NCI-H2052 cell growth in a cell viability assay, IC50=61.13 nM | SANGER |
NCI-H2342 cell | - | Growth inhibition assay | - | Inhibition of human NCI-H2342 cell growth in a cell viability assay, IC50=0.13445 μM | SANGER |
NKM-1 cell | - | Growth inhibition assay | - | Inhibition of human NKM-1 cell growth in a cell viability assay, IC50=0.1012 μM | SANGER |
NTERA-S-cl-D1 cell | - | Growth inhibition assay | - | Inhibition of human NTERA-S-cl-D1 cell growth in a cell viability assay, IC50=0.14357 μM | SANGER |
P30-OHK cell | - | Growth inhibition assay | - | Inhibition of human P30-OHK cell growth in a cell viability assay, IC50=0.22048 μM | SANGER |
PA-1 cell | - | Growth inhibition assay | - | Inhibition of human PA-1 cell growth in a cell viability assay, IC50=0.20128 μM | SANGER |
PANC-03-27 cell | - | Growth inhibition assay | - | Inhibition of human PANC-03-27 cell growth in a cell viability assay, IC50=0.1674 μM | SANGER |
QIMR-WIL cell | - | Growth inhibition assay | - | Inhibition of human QIMR-WIL cell growth in a cell viability assay, IC50=0.18189 μM | SANGER |
REH cell | - | Growth inhibition assay | - | Inhibition of human REH cell growth in a cell viability assay, IC50=0.14696 μM | SANGER |
RPMI-7951 cell | - | Growth inhibition assay | - | Inhibition of human RPMI-7951 cell growth in a cell viability assay, IC50=0.15609μM | SANGER |
RT-112 cell | - | Growth inhibition assay | - | Inhibition of human RT-112 cell growth in a cell viability assay, IC50=70.37 nM | SANGER |
SBC-5 cell | - | Growth inhibition assay | - | Inhibition of human SBC-5 cell growth in a cell viability assay, IC50=0.21546 μM | SANGER |
SCC-9 cell | - | Growth inhibition assay | - | Inhibition of human SCC-9 cell growth in a cell viability assay, IC50=0.19675 μM | SANGER |
SIG-M5 cell | - | Growth inhibition assay | - | Inhibition of human SIG-M5 cell growth in a cell viability assay, IC50=0.16986 μM | SANGER |
SK-LMS-1 cell | - | Growth inhibition assay | - | Inhibition of human SK-LMS-1 cell growth in a cell viability assay, IC50=0.10841 μM | SANGER |
SK-PN-DW cell | - | Growth inhibition assay | - | Inhibition of human SK-PN-DW cell growth in a cell viability assay, IC50=36.55 nM | SANGER |
SK-UT-1 cell growth | - | Growth inhibition assay | - | Inhibition of human SK-UT-1 cell growth in a cell viability assay, IC50=7.44 nM | SANGER |
SNU-423 cell | - | Growth inhibition assay | - | Inhibition of human SNU-423 cell growth in a cell viability assay, IC50=0.16307 μM | SANGER |
SR cell | - | Growth inhibition assay | - | Inhibition of human SR cell growth in a cell viability assay, IC50=0.14073 μM | SANGER |
ST486 cell | - | Growth inhibition assay | - | Inhibition of human ST486 cell growth in a cell viability assay, IC50=6.18 nM | SANGER |
SW1710 cell | - | Growth inhibition assay | - | Inhibition of human SW1710 cell growth in a cell viability assay, IC50=2.91 nM | SANGER |
SW982 cell | - | Growth inhibition assay | - | Inhibition of human SW982 cell growth in a cell viability assay, IC50=60.23 nM | SANGER |
T47D cell | - | Growth inhibition assay | - | Inhibition of human T47D cell growth in a cell viability assay, IC50=0.22306 μM | SANGER |
TE-441-T cell | - | Growth inhibition assay | - | Inhibition of human TE-441-T cell growth in a cell viability assay, IC50=2.24 nM | SANGER |
YKG-1 cell | - | Growth inhibition assay | - | Inhibition of human YKG-1 cell growth in a cell viability assay, IC50=0.22891 μM | SANGER |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT01968928 | - | - | Unknown | December 2016 | Taiwan ... more >> Department of Urology, National Taiwan University Hospital Not yet recruiting Taipei, Taiwan, 10002 Contact: Kuo-How Huang, M.D.,Ph.D. 886-2-23123456 ext 65952 khhuang123@ntu.edu.tw Principal Investigator: Kuo-How Huang, M.D.,Ph.D. Collapse << |
NCT01287468 | - | - | Unknown | December 2014 | Taiwan ... more >> Taipei Medical University - WanFang Hospital Taipei, Taiwan Collapse << |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网